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AbstrACt
Objective We assessed compliance with new guidelines 
for prophylactic antibiotics in hip fracture surgery in 
Norway introduced in 2013.
Design The data from the Norwegian Hip Fracture 
Register was used to assess the proportion of antibiotics 
given according to the national guidelines.
setting All hospitals in Norway performing hip fracture 
surgery in the period from 2011 to 2016.
Participants We studied 13 329 hemiarthroplasties (HAs) 
for acute hip fracture.
Main outcome measure Type and timing between first 
and last dose of prophylactic antibiotics compared with the 
national guidelines.
results Before the guidelines were introduced, the 
recommended drugs cephalotin or clindamycin was 
used in only 86.2% of all HAs. In 2016, one of the two 
recommended drugs was administered in 99.2% of 
HAs. However, hospitals’ adaption of the recommended 
administration of the two drugs improved slowly, and by 
the end of the study period, only three out of five HAs 
were performed with the correct drug administered in the 
correct manner. We found major differences in compliance 
between hospitals.
Conclusions The change towards correct administration 
of antibiotic prophylaxis was varied both when 
investigating university and non- university hospitals. 
We suggest that both hospital leaders and the national 
Directorate of Health need to investigate routines for 
better dissemination of information and education to 
involved parties. Strong leadership concerning evidence- 
based guidelines on antibiotic prophylaxis in surgery may 
take away some autonomy from executing healthcare 
professionals, but will result in better patient care and 
antibiotic stewardship.
IntrODuCtIOn
Due to the complexity of modern medi-
cine, guidelines and checklists have become 
a necessary part of treatment in all medical 
fields. For guidelines and checklists to have 
effect, it is imperative that they are used and 
followed. Until 2013, there were no national 
guidelines for prophylactic antibiotics in 
orthopaedic surgery in Norway, and many 
different regimens were used. Engesaeter et 
al1 found the lowest risk of revision, for any 
reason, if four doses of antibiotics were admin-
istered systemically on the day of surgery in 
total hip arthroplasty. Extended prophylaxis 
of 2 or 3 days did not decrease the revision 
risk compared with four doses administered 
on the day of surgery according to that study.
Guidelines for prophylactic antibiotics in 
orthopaedic surgery was first introduced in 
Norway in 2013.2 The guidelines were based 
on a thorough evaluation of available knowl-
edge, using the Grades of Recommendation 
Assessment, Development and Evaluation 
(GRADE) system3 as a tool for giving the 
best possible recommendations and were 
published on the Norwegian Directorate of 
Health’s website.2 The guidelines state that 
cephalotin, a first- generation cephalosporin, 
should be the only drug of choice, except in 
strengths and limitations of this study
 ► The strengths of our study are the high coverage 
and completeness of the Norwegian Hip Fracture 
Register combined with the large number of patient 
forms we were able to investigate.
 ► Another strength is that the forms are filled out by 
the surgeon immediately after surgery, thereby en-
suring correct information regarding prophylaxis.
 ► One limitation of our study is the lack of clear guide-
lines for clindamycin as a prophylactic drug.
 ► There may be a discrepancy between what was 
filled in on the form and the actual timing of the 
prophylaxis.
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Table 1 Type of antibiotic prophylaxis used from 2011 to 2016
2011 2012 2013 2014 2015 2016
Cephalotin total 1860 (82.6%) 1926 (90.0%) 1919 (93.1%) 2070 (95.0%) 2109 (95.2%) 2346 (94.8%)
  Correct administration (%) 86 (4.5%) 406 (19.6%) 955 (45.3%) 1379 (58.8%)
  Incorrect administration (%) 1833 (95.5%) 1664 (80.4%) 1154 (54.7%) 967 (41.2%)
Clindamycin total 82 (3.6%) 73 (3.4%) 86 (4.2%) 86 (3.9%) 97 (4.4%) 112 (4.5%)
  Correct administration (%) 74 (86%) 72 (83.7%) 83 (85.6%) 100 (89.3%)
  Incorrect administration (%) 12 (14%) 14 (16.3%) 14 (14.4%) 12 (10.7%)
Other drug 311 (13.8%) 142 (6.6%) 57 (2.7%) 24 (1.1%) 9 (0.4%) 16 (0.6%)
Total 2253 2141 2062 2180 2215 2474
  Correct administration (%) 7.8% 21.9% 46.9% 59.8%
  
cases of penicillin allergy, where clindamycin should be 
used instead.
Cephalotin has a half- life of about 45 min, and should, 
therefore, be administered at short intervals (the guide-
lines state an interval of 90 min), to exceed minimal 
inhibitory concentrations (MIC). It is also recommended 
that the first dose should be administered 30–60 min 
before the incision is made.4–7 Studies have shown that 
this first dose probably is the most important one.6 8 For 
arthroplasty procedures, four doses were recommended. 
In cases of known penicillin allergy, four doses of clinda-
mycin, administered every 6 hours, were recommended. 
When the guidelines were published, the aim was to 
improve administration of prophylactic antibiotics. From 
many different administration regimens, to a uniform 
regimen throughout Norway.
The aim of this study was to assess whether hospitals 
in Norway follow the new guidelines published by the 
Norwegian Directorate of Health, and if so, at what pace 
the guidelines were implemented.
MAterIAl AnD MethODs
The Norwegian Hip Fracture Register (NHFR) has 
collected data on all hip fracture procedures in Norway 
since 2005.9 The information about the patient, fracture 
and type of surgery, as well as type of antibiotic prophy-
laxis, number of doses and duration recorded as the 
time interval between the first and the last dose in hours 
is reported to the NHFR on a one- page questionnaire 
completed by the surgeon immediately after each surgery. 
The questionnaires are sent from each hospital to the 
NHFR database for registration. Both primary surgery 
and reoperations are registered. The completeness of 
reporting to the NHFR compared with the Norwegian 
Patient Registry has been found to be 94.5% for primary 
hemiarthroplasties (HAs).10
The data from 19 106 HAs due to femoral neck frac-
ture registered in the NHFR from 1 January 2011 to 31 
December 2016 were evaluated, spanning 2 years before 
and 4 years after publication of the new guidelines. In 
this studied period, around 90% of femoral neck fracture 
patients in Norway were treated with HA.10 Of these, some 
HAs had incomplete information on the total number of 
antibiotic doses (2521), type of antibiotic drug (107) and 
duration of prophylaxis (2805), and were excluded. We 
also excluded HAs where patients received more than 
one drug for prophylaxis (344). This left 13 329 HAs 
eligible for analyses.
One large hospital had a high number of excluded 
patients (n=1128). From that specific hospital, only 
323 cases had been correctly reported, representing an 
inclusion rate of only 22%. Therefore, this hospital was 
excluded from the analyses due to infrequent correct 
reporting. Excluding the remaining reported cases from 
that hospital did not change our findings. In compar-
ison, 27 hospitals had an inclusion rate of more than 
75% and only 9 had an inclusion rate of between 50% 
and 60%.
Analyses of number of doses and duration of cepha-
lotin prophylaxis revealed four main groups: completion 
of four doses within 4.5, 6, 12 and 24 hours, respectively. 
The timing of the first dose is not recorded in the NHFR, 
meaning that verification of whether this dose was given 
before surgery or not was not possible. We could, however, 
verify that doses were given at intervals short enough to 
keep concentrations above MIC. Stipulating that both 4.5 
and 6 hours could be interpreted as correct administra-
tion of four doses with intervals of 90 min, we decided to 
treat these as one group, leaving three groups for analyses: 
in the first group, completion of all doses was registered 
as administered during the first 6 hours postoperatively; 
in the second group, it was completed between 7 and 12 
hours postoperatively and in the third group, between 13 
and 24 hours postoperatively. Four doses of cephalotin 
administered during the first 6 hours postoperatively 
were defined as the correct administration according to 
the guidelines.
The first version of the guidelines did not contain 
recommendations on number of doses or dosage for 
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Table 2 Patient characteristics
Correct antibiotic and 
administration as stated in 
the guidelines of 2013
Incorrect antibiotic or 
administration as stated in 
the guidelines of 2013 All groups
Total number of HAs 3316 10 013 13 329
Age, mean 82.9 82.5 82.6
Gender, male (%) 1010 (30.5) 3020 (30.2) 4030 (30.2)
Dementia, no (%) 2047 (61.7) 6352 (63.4) 8399 (63)
Dementia, yes (%) 901 (27.2) 2564 (25.6) 3465 (26)
Dementia, uncertain (%) 306 (9.2) 908 (9.1) 1214 (9.1)
Dementia, missing (%) 62 (1.9) 189 (1.9) 251 (1.9)
ASA 1 (%) 29 (0.9) 122 (1.2) 151 (1.1)
ASA 2 (%) 997 (30.1) 3258 (32.5) 4255 (31.9)
ASA 3 (%) 1998 (60.3) 5872 (58.6) 7870 (59)
ASA 4 (%) 261 (7.9) 661 (6.6) 922 (6.9)
ASA 5 (%) 2 (0.1) 9 (0.1) 11 (0.1)
Missing ASA (%) 29 (0.9) 91 (0.9) 120 (120)
Anterolateral approach (%) 183 (5.5) 741 (7.4) 924 (6.9)
Direct lateral approach (%) 2466 (74.4) 8271 (82.6) 10 737 (80.6)
Posterior approach (%) 634 (19.1) 811 (8.1) 1445 (10.6)
Other/missing approach (%) 33 (1) 190 (1.9) 223 (1.7)
Figure 1 Antibiotic prophylaxis and hemiarthroplasty—all hospitals.
clindamycin given over a period of 8–24 hours were 
defined as the correct administration according to the 
guidelines.
Treatments for all types of hip fractures are included 
in the NHFR. HAs account for approximately 34% of the 
total number of registered operations. More than 90% 
of the displaced femoral neck fractures in patients older 
than 70 years are treated with an HA, so the included 
operations make up the vast majority of the surgeries for 
these fractures. We did not include hip fractures treated 
with any form of osteosynthesis, as the recommendations 
in the guidelines are prophylaxis during surgery, and not 
after as is the case with HAs. Most HAs are performed 
by junior registrars, whereas total hip arthroplasties are 
performed by consultants specialising in hip surgery. 
We, therefore, excluded hip fractures treated with total 
hip arthroplasty to remove bias from more experienced 
surgeons.
We analysed 6 university hospitals and 44 non- university 
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Figure 2 Indicator if new guidelines for antibiotics are followed—all hospitals.
Figure 3 Indicator if new guidelines for antibiotics are followed—university hospitals.
cephalotin or clindamycin was used, we recorded whether 
it was administered correctly, and if there were any 
changes in their use from 2011 to 2016. We also assessed 
compliance, defined as 100% correct administration as 
described in the guidelines.
Descriptive statistics
The quarterly compliance with the national guidelines 
during 2011–2016 was calculated both for university 
hospitals and non- university hospitals. One university 
hospital submitted a high number of incomplete forms 
to the NHFR during the whole study period, and was 
consequently excluded from the comparisons of univer-
sity hospitals. Analyses were performed using IBM SPSS, 
V.24.0 (IBM Corp.) and the statistical package R V.3.4.0 
(http://www. R- project. org).
Patients and public involvement
This research was conducted without patient involve-
ment. Patients were not invited to comment on the study 
design and were not consulted to develop patient rele-
vant outcomes or interpret the results. Patients were not 
invited to contribute to the writing or editing of this docu-
ment for readability or accuracy.
The NHFR has permission from the Norwegian Data 
Protection Authority to collect and store data on hip frac-
ture treatment (permission granted on 3 January 2005: 
reference number 2004/1658–2 SVE/−). The patients 
have signed a written, informed consent, and in case 
they were not able to sign, their next of kin could sign 
the consent form on their behalf. This study only used 
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done. The study was, therefore, performed in accordance 
with the regulations from the Norwegian Data Protection 
Authority and no ethics approval was necessary.
results
types of antibiotics used 2011–2016
In 2011, 99.6%11 of HAs received intravenous antibiotic 
prophylaxis, but cephalotin or clindamycin was used 
in only 86.2% of all HAs. This number rose steadily 
throughout the study period: in 2016, one of the two 
recommended drugs was administered in 99.2% of HAs. 
There was a small increase in the use of clindamycin 
during the period, whereas other antibiotics were gradu-
ally abandoned (table 1).
Compliance with the national guidelines
Table 2 shows baseline data for the 13 329 HAs included 
in the compliance analyses, dividing antibiotic prophy-
laxis according to the guidelines and other regimens. 
The groups were similar in age, gender, American Society 
of Anesthesiologists (ASA) class and cognitive function. 
HAs performed with a posterior approach were more 
often performed with the correct prophylactic regime 
compared with other surgical approaches. 10.8% of HAs 
in the study period were performed using a posterior 
approach. In 2011, only 4% of the HAs were performed 
with antibiotic prophylaxis as later recommended in the 
guidelines of 2013. We found a small but marked change 
towards administration of all four doses of cephalotin 
within 6 hours during 2014 (figure 1). However, for 
clindamycin, no such trend was found. Although better 
than cephalotin, erronous administration remained at 
10%–15% for the whole study period. This meant that 
only 21.9% of HAs received antibiotic prophylaxis in 
concordance with the guidelines in 2014.
The proportion of patients receiving correct admin-
istration of cephalotin increased steadily after 2014 and 
towards the end of the study period. In 2016, almost 60% 
of all registered HAs were performed with prophylaxis 
as recommended in the guidelines (figure 2). There 
were major differences between hospitals. Some hospi-
tals showed a rapid change of practice shortly after the 
guidelines had been published, whereas others had yet to 
comply with the guidelines by the end of 2016. Two of the 
five university hospitals changed their routines according 
to the guidelines during the first months after they were 
published, two gradually became compliant and one did 
not comply at all (figure 3). University hospitals adapted 
to the new guidelines faster than non- university hospitals. 
There was, however, a similar rise in correct administra-
tion in both hospital categories (figure 2).
DIsCussIOn
The change towards correct administration of antibiotic 
prophylaxis in HAs for hip fracture was slow after intro-
duction of the national guidelines. At the end of the study 
period, only three out of five HAs were performed with 
the correct drug administered in the correct manner. 
Most university hospitals adapted to the new guidelines 
faster than non- university hospital, but one university 
hospital did not comply with the guidelines at all.
From a quality control perspective, any contemplated 
changes to a process must be thoroughly evaluated to 
fully assess their impact. This is a part of Shewhart’s four- 
part cycle of Plan, Do, Study and Act,12 and an essential 
part in improving the quality of any process. When the 
new guidelines were published, it was after an exten-
sive evaluation (Plan). The introduction was performed 
by distributing the new guidelines by email and with 
lectures held around the country and publication on 
the National Directorate of Health webpage (Do). We 
now need to evaluate whether hospitals follow the new 
guidelines, and whether following the guidelines has 
any effect on infection rates (Study). If Norwegian hospi-
tals do not follow the guidelines, we need to understand 
why, and if there are differences in antibiotic regimes 
that lead to differences in infection rates, we then need 
to act (Act).
Prophylactic antibiotics are known to have a major 
impact on infection risk.8 It is the single most important 
prophylactic measure against surgical site infections.13–16 
We found a gradual increase in adherence to the Norwe-
gian guidelines published in 2013. Recommendations on 
time between doses were slowly implemented, and at the 
end of the study period, still less than 60% of the HAs 
were performed with antibiotic prophylaxis according to 
the guidelines. University hospitals were faster at adapting 
the new guidelines than non- university hospitals.
Several studies have reported on adherence to guide-
lines with regards to surgical antibiotic prophylaxis,17–21 
with varying results. A Dutch study22 showed that guide-
lines can be effective in improving the process of care, 
but that there are large differences in the impact of each 
guideline. When evaluating the influence of a guide-
line, the first and most important factor to examine is 
whether the guidelines actually are being followed. If 
guidelines are not being followed, we need to under-
stand why. Grimshaw and Russell23 suggested a classifica-
tion for probability of success when implementing new 
guidelines, where local education of clinicians was the 
most important factor. He also advocated rigorous eval-
uation of existing guidelines. Cabana et al24 gave seven 
reasons for why clinicians do not follow practical guide-
lines. All these barriers can, in our opinion, be over-
come by strong leadership and education of the health 
practitioners.
There is clear evidence that checklists may have a posi-
tive impact on results.25–28 A study from 2011 concluded 
that leaders are a key factor in the implementation and 
further utilisation of checklists.29 Another tool that is avail-
able is a statistical process control (SPC).30 This has been 
used for monitoring processes in real time in the process 
industry for many years and is gradually becoming a part 
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type of drug
Cephalotin is not the most potent antibiotic against post-
operative infections. But, when considering antibiotic 
stewardship and common bacteria causing postoperative 
infections, it has been considered the best choice for 
antibiotic prophylaxis in HAs in Norway. A more broad- 
spectrum antibiotic prophylaxis will probably yield fewer 
postoperative infections, but would at the same time be 
ecologically unwanted.
In our study population, cephalotin and clindamycin 
were already the two most commonly used prophylactic 
antibiotics in HA surgery before the guidelines were 
published. There was an increase in use of these antibi-
otics during the study period, reaching almost complete 
adherence in choice of drug with the guidelines. There 
may always be indications for using other antibiotics, 
such as concomitant medical conditions. We, therefore, 
conclude that, when it comes to the type of antibiotic, 
Norwegian orthopaedic surgeons are adherent to today’s 
guidelines.
timing
Correct timing of antibiotics, defined as the recorded 
time interval in hours between first and last doses, should 
ensure that the concentration of antibiotics in the tissue 
stays above MIC at all times. With the short half- life of 
cephalotin, this can only be achieved by short intervals 
between doses.
In our study, two out of five HAs were performed with 
cephalotin prophylaxis using intervals exceeding 90 min, 
4 years after the introduction of the guidelines. Given 
today’s guidelines, and understanding of how prophy-
lactic antibiotics work, deviance from them is unrecom-
mendable. Less than 60% adherence to the national 
guidelines 4 years after the introduction of new guidelines 
may necessitate an intervention by local hospital leaders 
as well as the Norwegian Directorate of Health.
Differences between hospitals
University hospitals should be at the forefront of change, 
and up to date on current knowledge. It is problematic 
that one university hospital did not comply with the obli-
gation of reporting to the quality register (NHFR). This 
ought to be corrected (Act). It is also noticeable that one 
of the six university hospitals did not comply with the 
guidelines. In our opinion, there is no excuse for such 
oversight, and it should be remedied. Again, local leaders 
need to be involved, if not the National Directorate of 
Health may have to intervene. In Norway, each hospital 
generally uses one surgical approach and one standard 
prophylaxis for HAs. It is rare, if not non- existent, to 
find one hospital using several different approaches 
or allowing the administration of different antibiotic 
prophylaxis on a surgeon- by- surgeon basis. This may 
explain the difference we found when comparing surgical 
approaches. One of the few hospitals using the posterior 
approach was almost 100% adherent to the guidelines, 
thus giving this difference.
strengths/weaknesses
The high number of procedures included and that nation-
wide results are presented are both strengths in the present 
study. When studying a large population using register- 
based data, there are some inherent weaknesses.31 Most 
are connected to the questionnaire and the completeness 
of the registry. The coverage in the NHFR is 100% and 
the completeness is 94.5% for HAs.10 This high complete-
ness in the NHFR yields a low selection bias and a high 
external validity of our results. Our data are limited by the 
questions and registrations on the operation form filled 
in by the surgeons. There is a possibility that the antibiotic 
prophylaxis actually given may be different from what the 
surgeon records. For example, Stefánsdóttir et al32 showed 
in 2009 that although recommendations for timing of the 
preoperative antibiotic infusion were known, only 51% 
of the patients received it correctly. However, we have no 
reason to expect a systematically incorrect reporting from 
the surgeons. The timing of the first dose of antibiotic 
prophylaxis is not reported to the NHFR. This informa-
tion would have strengthened our study on adherence to 
the national guidelines, but would have been even more 
important in a study investigating the benefit of correct 
antibiotic. The lack of clear guidelines for clindamycin 
when the guidelines were published is problematic when 
interpreting the results. However, we argue that allowing 
for the use of either two sets of guidelines available in the 
period removes some of the problem. That being said, we 
recognise this as problematic.
A high number of cases were excluded due to incom-
plete information on the operation forms. The excluded 
cases demonstrated similar baseline characteristics as the 
included patients (for all variables presented in table 2). 
They were excluded during the whole period we inves-
tigated (between 13% and 18% each year). Further-
more, except for one hospital, the excluded cases had 
been reported fairly evenly from all hospitals. A more 
complete registration would have increased the number 
of cases investigated, and accordingly strengthened our 
results. We do not know for sure whether the excluded 
cases represent a systematic reporting of incomplete data, 
or represent a random selection of cases which probably 
have had antibiotic prophylaxis according to the hospi-
tal’s routine at the time of operation. However, we do 
know that this incomplete reporting comes from most of 
the reporting hospitals during the whole period investi-
gated. There is, therefore, a reason to believe that most 
excluded patients had received either correct or wrong 
antibiotic prophylaxis. We, therefore, believe that the 
included cases make up a representative selection and 
can still be used to investigate compliance with guidelines 
at Norwegian hospitals, but we also acknowledge that the 
missing cases represent a weakness of our study.
COnClusIOn
The national guidelines have gradually become imple-




ugust 11, 2020 at H










pen: first published as 10.1136/bm





7Lian T, et al. BMJ Open 2020;10:e035598. doi:10.1136/bmjopen-2019-035598
Open access
correct use of antibiotic immediately after the introduc-
tion of the guidelines was only found in a few hospitals. 
Throughout the country, hospitals still fail to comply with 
the guidelines. This must be addressed, both when eval-
uating existing guidelines as well as when planning new 
guidelines. As long as guidelines are based in evidence, 
there are few, if any, reasons not to follow them.
By using checklists and combining them with the 
SPC data, it should be possible to follow processes and 
intervene when they are not stable. No single hospital 
in our study showed 100% adherence to the guidelines. 
This shows that there still exist individual surgeons not 
adherent to hospital policy and the national guidelines. 
Early identification of non- compliance needs be brought 
to the attention of local leaders. If this does not lead 
to change, the National Directorate of Health and the 
public should be notified.
Modern medicine is complex and dependent on 
compliance to evidence- based guidelines. Eminence- 
based medicine may still be warranted in some areas, but 
in fields where there are evidence- based guidelines it has 
no place. To conclude, we advocate more guidelines in 
complex and well- studied fields in medicine and strong 
adherence to existing ones.
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